Forward Citations = 130

Loading Chart...

4 inventors (with patents filed for the assignee):

Leslie L Balassa (5 out of 10 patents)

John F Prudden (4 out of 4 patents)

William T Sherman (1 out of 2 patents)

4. Robert W Gracy (1 out of 2 patents)

8 patents: Sort by Forward Citations

1. 6117851 - Treatment of osteoarthritis by administering poly-N-acetyl-D-glucosamine (2000-09-12),

2. 4822607 - Anti-tumor agent and method (1989-04-18),

3. 4656137 - Method of processing animal cartilage (1987-04-07),

4. 4444752 - Method for treating progressive systemic sclerosis (1984-04-24),

5. 4350682 - Cartilage extraction processes and products (1982-09-21),

6. 4212857 - Method for stimulating the production of immunoglobulin and total (1980-07-15),

7. 4006224 - Method and agent for treating inflammatory disorders of the (1977-02-01),

8. 3966908 - Method of treating degenerative joint afflictions (1976-06-29),

Company Overview

Lescarden Inc. is a leading pharmaceutical company specializing in producing innovative solutions for skin care and dermatological conditions. With a strong focus on research and development, Lescarden Inc. has created a range of products that have been proven to be effective in treating various skin ailments. Their commitment to quality and customer satisfaction sets them apart in the industry.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 13 2026

8 Patents

#824 in New York, NY

#2,105 in New York

#35,924 in US

New York, NY, United States of America

Lescarden Inc.

Forward Citations = 130

4 inventors:

Leslie L Balassa (5 out of 10 patents)

John F Prudden (4 out of 4 patents)

William T Sherman (1 out of 2 patents)

4. Robert W Gracy (1 out of 2 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Lescarden Inc.. Retrieved from https://idiyas.com/company/lescarden

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]